Feb. 27 (Bloomberg) -- The following stocks may rise or fall in Israeli markets. Stock symbols are in parentheses after the company names and prices are from the close unless otherwise stated.
The TA-25 Index declined 1.8 percent to 1,272.62 in Tel Aviv.
Ampal-American Israel Corp. (AMPL IT): The flow of gas from Egypt may be delayed a few days, TheMarker business daily reported, citing an Israeli government evaluation. The holding company that imports the fuel earlier said it expected resumption by the end of February. Ampal-American dropped 2.9 percent to 7.066 shekels.
Bioline RX Ltd. (BLRX IT): The biopharmaceutical company said a trial to test the safety and effectiveness of BL-1040 in post heart-attack patients will start in the second half. Bioline declined 1.3 percent to 2.724 shekels.
Partner Communications Co. (PTNR IT): The country’s second-largest mobile phone company was raised to “market perform” from “underperform” at Meitav Investment House Ltd. Partner fell 1.7 percent to 66.87 shekels.
Protalix BioTherapeutics Inc. (PLX IT): The biotechnology company failed to win U.S. approval of a plant-based medicine it’s developing with Pfizer Inc. to treat Gaucher disease. Protalix gained 3.4 percent to 36.20 shekels.
Space Communication Ltd. (SCC IT): The supplier of satellite communications services said it plans to offer Series Yud-Aleph bonds under a shelf registration originally filed in February 2010. Space Communication slipped 0.2 percent to 69.86 shekels.
To contact the editor responsible for this story: Claudia Maedler at firstname.lastname@example.org